The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 10 results:
Author Title [ Type(Desc)] Year
Filters: Author is Karamouzis, Michalis V  [Clear All Filters]
Journal Article
Sgourakis, G., Papapanagiotou A., Kontovounisios C., Karamouzis M. V., Dedemadi G., Goumas C., et al. (2014).  The combined use of serum neurotensin and IL-8 as screening markers for colorectal cancer.. Tumour Biol. 35(6), 5993-6002.
Pallis, A. G., & Karamouzis M. V. (2010).  DNA repair pathways and their implication in cancer treatment.. Cancer Metastasis Rev. 29(4), 677-85.
Pallis, A. G., Karamouzis M. V., Konstantinopoulos P. A., & Papavassiliou A. G. (2010).  Molecular networks in respiratory epithelium carcinomas.. Cancer Lett. 295(1), 1-6.
Gargalionis, A. N., Karamouzis M. V., & Papavassiliou A. G. (2014).  The molecular rationale of Src inhibition in colorectal carcinomas.. Int J Cancer. 134(9), 2019-29.
Iliopoulou, E. G., Kountourakis P., Karamouzis M. V., Doufexis D., Ardavanis A., Baxevanis C. N., et al. (2010).  A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer.. Cancer Immunol Immunother. 59(12), 1781-9.
Argiris, A., Karamouzis M. V., Gooding W. E., Branstetter B. F., Zhong S., Raez L. E., et al. (2011).  Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer.. J Clin Oncol. 29(9), 1140-5.
Zachos, I., Konstantinopoulos P. A., Tzortzis V., Gravas S., Karatzas A., Karamouzis M. V., et al. (2010).  Systemic therapy of metastatic bladder cancer in the molecular era: current status and future promise.. Expert Opin Investig Drugs. 19(7), 875-87.
Karamouzis, M. V., & Papavassiliou A. G. (2014).  Tackling the cancer signal transduction “labyrinth”: a combinatorial use of biochemical tools with mathematical models will enhance the identification of optimal targets for each molecular defect.. Cancer. 120(3), 316-22.
Nigdelis, M. P., Karamouzis M. V., Kontos M., Alexandrou A., Goulis D. G., & Lambrinoudaki I. (2021).  Updates on the treatment of invasive breast cancer: Quo Vadimus?. Maturitas. 145, 64-72.
Sgourakis, G., Papapanagiotou A., Kontovounisios C., Karamouzis M. V., Lanitis S., Konstantinou C., et al. (2013).  The value of plasma neurotensin and cytokine measurement for the detection of bowel ischaemia in clinically doubtful cases: a prospective study.. Exp Biol Med (Maywood). 238(8), 874-80.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.